{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:52:18Z","timestamp":1785174738261,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA036727"],"award-info":[{"award-number":["P30 CA036727"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA258621"],"award-info":[{"award-number":["R01 CA258621"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bmcl.2024.129659","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T11:34:05Z","timestamp":1708169645000},"page":"129659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["\u03b1-Amino bisphosphonate triazoles serve as GGDPS inhibitors"],"prefix":"10.1016","volume":"102","author":[{"given":"Nathaniel R.","family":"Gehrke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.","family":"Ayub Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona A.","family":"Maalouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Holstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Wiemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bmcl.2024.129659_b0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1083\/jcb.201612069","article-title":"Rho GTPase signaling complexes in cell migration and invasion","volume":"217","author":"Lawson","year":"2018","journal-title":"The Journal of cell biology"},{"issue":"32","key":"10.1016\/j.bmcl.2024.129659_b0010","doi-asserted-by":"crossref","first-page":"11821","DOI":"10.1073\/pnas.0601617103","article-title":"Rabs and their effectors: achieving specificity in membrane traffic","volume":"103","author":"Grosshans","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1016\/j.bmcl.2024.129659_b0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrc3151","article-title":"Targeting protein prenylation for cancer therapy","volume":"11","author":"Berndt","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bmcl.2024.129659_b0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/21678707.2014.872028","article-title":"The role of the farnesyltransferase inhibitor lonafarnib in the treatment of Progeria","volume":"2","author":"Kieran","year":"2014","journal-title":"Expert Opinion on Orphan Drugs"},{"issue":"16","key":"10.1016\/j.bmcl.2024.129659_b0025","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.2018.3264","article-title":"Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome","volume":"319","author":"Gordon","year":"2018","journal-title":"Jama-Journal of the American Medical Association"},{"issue":"41","key":"10.1016\/j.bmcl.2024.129659_b0030","doi-asserted-by":"crossref","first-page":"16666","DOI":"10.1073\/pnas.1202529109","article-title":"Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome","volume":"109","author":"Gordon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20132","key":"10.1016\/j.bmcl.2024.129659_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09687688.2016.1213432","article-title":"Molecular mechanisms linking geranylgeranyl diphosphate synthase to cell survival and proliferation","volume":"33","author":"Agabiti","year":"2016","journal-title":"Mol. Membr. Biol."},{"issue":"6","key":"10.1016\/j.bmcl.2024.129659_b0040","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3390\/molecules22060886","article-title":"Recent advances in the development of mammalian geranylgeranyl diphosphate synthase inhibitors","volume":"22","author":"Haney","year":"2017","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bmcl.2024.129659_b0045","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.leukres.2010.08.008","article-title":"Isoprenoid biosynthetic pathway inhibition disrupts monoclonal protein secretion and induces the unfolded protein response pathway in multiple myeloma cells","volume":"35","author":"Holstein","year":"2011","journal-title":"Leuk. Res."},{"issue":"39","key":"10.1016\/j.bmcl.2024.129659_b0050","doi-asserted-by":"crossref","first-page":"41535","DOI":"10.18632\/oncotarget.6365","article-title":"Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells","volume":"6","author":"Dykstra","year":"2015","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.bmcl.2024.129659_b0055","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1021\/acs.jmedchem.8b00886","article-title":"Unraveling the Prenylation-Cancer Paradox in Multiple Myeloma with Novel Geranylgeranyl Pyrophosphate Synthase (GGPPS) Inhibitors","volume":"61","author":"Lacbay","year":"2018","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bmcl.2024.129659_b0060","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.bmc.2006.02.010","article-title":"Synthesis and biological activity of isoprenoid bisphosphonates","volume":"14","author":"Shull","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bmcl.2024.129659_b0065","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.bbrc.2006.12.094","article-title":"Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase","volume":"353","author":"Wiemer","year":"2007","journal-title":"Biophys. Res. Commun."},{"issue":"18","key":"10.1016\/j.bmcl.2024.129659_b0070","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1021\/jm800325y","article-title":"Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: A crystallographic and computational investigation","volume":"51","author":"Chen","year":"2008","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bmcl.2024.129659_b0075","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.bmc.2014.03.014","article-title":"Geranyl and neryl triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase","volume":"22","author":"Zhou","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.bmcl.2024.129659_b0080","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1021\/acsmedchemlett.5b00334","article-title":"Potent Triazole Bisphosphonate Inhibitor of Geranylgeranyl Diphosphate Synthase","volume":"6","author":"Wills","year":"2015","journal-title":"ACS Med Chem Lett"},{"issue":"2","key":"10.1016\/j.bmcl.2024.129659_b0085","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bmc.2017.10.023","article-title":"alpha-Methylation enhances the potency of isoprenoid triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors","volume":"26","author":"Matthiesen","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bmcl.2024.129659_b0090","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1124\/jpet.119.258624","article-title":"In Vivo Evaluation of Isoprenoid Triazole Bisphosphonate Inhibitors of Geranylgeranyl Diphosphate Synthase: Impact of Olefin Stereochemistry on Toxicity and Biodistribution","volume":"371","author":"Haney","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bmcl.2024.129659_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116307","article-title":"Impact of alpha-modifications on the activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors","volume":"44","author":"Fairweather","year":"2021","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.bmcl.2024.129659_b0100","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.bmc.2014.03.014","article-title":"Geranyl and neryl triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase","volume":"22","author":"Zhou","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"39","key":"10.1016\/j.bmcl.2024.129659_b0105","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1021\/ja050622q","article-title":"The allylic azide rearrangement: Achieving selectivity","volume":"127","author":"Feldman","year":"2005","journal-title":"J. Am. Chem. Soc."},{"issue":"22","key":"10.1016\/j.bmcl.2024.129659_b0110","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1021\/acs.joc.9b02298","article-title":"ZnCl2-Mediated Double Addition of Dialkylphosphite to Nitriles for the Synthesis of 1-Aminobisphosphonates","volume":"84","author":"Kaboudin","year":"2019","journal-title":"J. Org. Chem."},{"issue":"9","key":"10.1016\/j.bmcl.2024.129659_b0115","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/mrc.1270070907","article-title":"C-13 NMR Spectra of Monoterpenes","volume":"7","author":"Bohlmann","year":"1975","journal-title":"Organic Magnetic Resonance"},{"key":"10.1016\/j.bmcl.2024.129659_b0120","doi-asserted-by":"crossref","first-page":"164","DOI":"10.15227\/orgsyn.064.0164","article-title":"Selective hydroboration of a 1,3,7-triene: homogeraniol","volume":"64","author":"Leopold","year":"1986","journal-title":"Org. Synth."},{"issue":"14","key":"10.1016\/j.bmcl.2024.129659_b0125","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/ja00093a010","article-title":"Allylbarium reagents - unprecedented regioselective and stereoselective allylation reactions of carbonyl-compounds","volume":"116","author":"Yanagisawa","year":"1994","journal-title":"J. Am. Chem. Soc."},{"issue":"19","key":"10.1016\/j.bmcl.2024.129659_b0130","doi-asserted-by":"crossref","first-page":"9438","DOI":"10.1021\/acs.joc.6b01693","article-title":"Stereoselective Synthesis of Homoneryl and Homogeranyl Triazole Bisphosphonates","volume":"81","author":"Matthiesen","year":"2016","journal-title":"J. Org. Chem."},{"issue":"8","key":"10.1016\/j.bmcl.2024.129659_b0135","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.bmc.2017.02.066","article-title":"Bishomoisoprenoid triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase","volume":"25","author":"Wills","year":"2017","journal-title":"Biorg. Med. Chem."},{"issue":"19","key":"10.1016\/j.bmcl.2024.129659_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126633","article-title":"omega-Hydroxy isoprenoid bisphosphonates as linkable GGDPS inhibitors","volume":"29","author":"Bhuiyan","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.bmcl.2024.129659_b0145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/mol.116.107326","article-title":"Olefin Isomers of a Triazole Bisphosphonate Synergistically Inhibit Geranylgeranyl Diphosphate Synthase","volume":"91","author":"Allen","year":"2017","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bmcl.2024.129659_b0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/leu.2013.174","article-title":"Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications","volume":"28","author":"Bjorklund","year":"2014","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.bmcl.2024.129659_b0155","article-title":"Clinical and Biological Characteristics of Medullary and Extramedullary Plasma Cell Dyscrasias","volume":"10","author":"Janjetovic","year":"2021","journal-title":"Biology-Basel"},{"issue":"3","key":"10.1016\/j.bmcl.2024.129659_b0160","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1039\/B910552M","article-title":"Therapeutic applications of hyaluronan","volume":"6","author":"Gaffney","year":"2010","journal-title":"Molecular Biosystems"},{"issue":"11","key":"10.1016\/j.bmcl.2024.129659_b0165","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1158\/1078-0432.CCR-12-3752","article-title":"<i>In Vitro<\/i> and <i>In Vivo<\/i> Antitumor Activity of a Novel Alkylating Agent, Melphalan-Flufenamide, against Multiple Myeloma Cells","volume":"19","author":"Chauhan","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bmcl.2024.129659_b0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/128_2014_561","article-title":"Prodrugs of Phosphonates and Phosphates: Crossing the Membrane Barrier","volume":"360","author":"Wiemer","year":"2015","journal-title":"Top. Curr. Chem."},{"issue":"1","key":"10.1016\/j.bmcl.2024.129659_b0175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1158\/1535-7163.MCT-23-0358","article-title":"Structural Insight into Geranylgeranyl Diphosphate Synthase (GGDPS) for Cancer Therapy","volume":"23","author":"Pham","year":"2024","journal-title":"Mol. Cancer Ther."}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24000611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24000611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:50:18Z","timestamp":1760773818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24000611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":35,"alternative-id":["S0960894X24000611"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129659","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-Amino bisphosphonate triazoles serve as GGDPS inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129659"}}